Intravenous boluses and continuous infusions of L‐DOPA methyl ester in fluctuating patients with Parkinson's disease

Movement Disorders

Volumn 7, Issue 3, 1992, Pages 249-256

  Stocchi, F ^a   Ruggieri, S ^a   Carta, A ^a   Ryatt, J ^b   Quinn, N ^c   Jenner, P ^b   Marsden, C D ^c   Agnoli, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Institute of Neurology   (United Kingdom)

Author keywords

Intravenous administration; L DOPA; L DOPA methyl ester; Parkinson's disease; Plasma levels; On off fouctuations

Indexed keywords

CARBIDOPA; LEVODOPA; LEVODOPA METHYL ESTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ON OFF PHENOMENON; PARKINSON DISEASE;

AGED; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; INFUSIONS, INTRAVENOUS; LEVODOPA; MALE; MIDDLE AGE; MOTOR SKILLS; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; SUPPORT, NON-U.S. GOV'T;

EID: 0026766041     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.870070311     Document Type: Article

References (9)

1. Control of on/off phenomenon by continuous intravenous infusion of levodopa
2. L‐DOPA esters as potential prodrugs. Part II: chemical and enzymatic hydrolysis
3. Biochemical and behavioural effects of l‐DOPA methyl ester in cats treated with reserpine
4. L‐DOPA methyl ester –a candidate for chronic systemic delivery of l‐DOPA in Parkinson's disease
5. L‐DOPA esters as potential produgs: behavioural activity in experimental models of Parkinson's disease
6. L‐DOPA esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized mice
7. Intravenous dopamine agonist studies in Parkinson's disease
8. Levodopa methyl ester treatment of Parkinson's disease
9. The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism